GMP ¼¼Æ÷ Ä¡·á¿ë ¼Ò¸ðǰ ½ÃÀå : Á¦Ç° À¯Çüº°, ¼¼Æ÷ À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
GMP Cell Therapy Consumables Market, By Product Type, By Cell Type, By Application, By End User, By Geography
»óǰÄÚµå : 1705650
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,165,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,590,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,701,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Àü ¼¼°è GMP ¼¼Æ÷ Ä¡·á¿ë ¼Ò¸ðǰ ½ÃÀåÀº 2025³â¿¡´Â 1,800¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç 2032³â¿¡´Â 1¾ï 380¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 28.4%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 1,800¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR 28.40 2032³â °¡Ä¡ ¿¹Ãø 1¾ï 380¸¸ ´Þ·¯
±×¸². GMP ¼¼Æ÷ Ä¡·á¿ë ¼Ò¸ðǰ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2025³â
GMP Cell Therapy Consumables Market-IMG1

GMP ¼¼Æ÷ Ä¡·á¿ë ¼Ò¸ðǰ ¼¼°è ½ÃÀå ¼ºÀåÀº ¾Ï°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¼¼Æ÷ Ä¡·á´Â ȯÀÚ³ª ±âÁõÀÚÀÇ ¸ö¿¡¼­ ¼¼Æ÷¸¦ ÃßÃâÇÏ¿© Áúº´°ú ½Î¿ì±â À§ÇØ ¼¼Æ÷¸¦ º¯Çü½ÃŰ´Â °ÍÀ» Æ÷ÇÔÇϸç, GMP ¼Ò¸ðǰÀº ¼¼Æ÷ Ä¡·á Á¦Ç° °³¹ß ¹× Á¦Á¶ ½Ã ¹«±Õ¼ºÀ» º¸ÀåÇÏ°í ¿À¿°À» ¹æÁöÇϱâ À§ÇØ ¼¼Æ÷ Ä¡·á ÀýÂ÷¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¼¼Æ÷ ±â¹Ý ¿¬±¸¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø Áõ°¡, ¸¸¼ºÁúȯ¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ÀÇ Áõ°¡, ÀÇ·áºñ ÁöÃâ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ Àü ¼¼°èÀûÀ¸·Î ¼¼Æ÷ Ä¡·á¿ë GMP ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ¼¼Æ÷ Ä¡·áÁ¦ °³¹ß°ú °ü·ÃµÈ ³ôÀº ºñ¿ë°ú GMP ½Ã¼³¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ÁöħÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è GMP ¼¼Æ÷ Ä¡·á¿ë ¼Ò¸ðǰ ½ÃÀåÀÇ ¼ºÀåÀº Àü ¼¼°è ¾Ï ¹× ±âŸ ¸¸¼ºÁúȯÀÇ ¹ßº´·ü Áõ°¡¿Í °°Àº ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖÀ¸¸ç, ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ ¹ßÇ¥¿¡ µû¸£¸é 2018³â ¾ÏÀ¸·Î ÀÎÇÑ ½Å±Ô ȯÀÚ ¼ö´Â 1,810¸¸ ¸í, »ç¸ÁÀÚ ¼ö´Â 960¸¸ ¸íÀ¸·Î Áõ°¡ÇÏ¿´´Ù°í ÇÕ´Ï´Ù. ÀÌ¿¡ µû¶ó ¼¼Æ÷ Ä¡·á¿Í °°Àº ÷´Ü Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, GMP ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °ø°ø ¹× ¹Î°£ ±â°üÀÇ ¼¼Æ÷ ±â¹Ý ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ È®´ë´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ±¹¸³º¸°Ç¿ø(National Institutes of Health)Àº 2022³â ¼¼Æ÷ Ä¡·á ¿¬±¸¿¡ 1¾ï 5,000¸¸ ´Þ·¯ ÀÌ»óÀ» ÅõÀÚÇÒ ¿¹Á¤ÀÔ´Ï´Ù. ±×·¯³ª ¼¼Æ÷ Ä¡·áÁ¦ °³¹ß ¹× GMP ½Ã¼³ À¯Áö¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖÀ¸¸ç, GMP Á¦Á¶¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀº ¼¼Æ÷ Ä¡·áÁ¦ Á¦Ç°ÀÇ ±¤¹üÀ§ÇÑ »ó¿ëÈ­¸¦ ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼¼Æ÷ Ä¡·áÁ¦ °ü·Ã »óȯ ¹®Á¦°¡ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. Á¦Á¶ °øÁ¤À» °£¼ÒÈ­ÇÏ´Â GMP ¼Ò¸ðǰÀÇ Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀü°ú ¼¼Æ÷ Ä¡·áÁ¦ÀÇ »ç¿ë Áõ°¡´Â ½ÃÀå ±â¾÷µé¿¡°Ô ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¼¼°èÀÇ GMP ¼¼Æ÷ Ä¡·á¿ë ¼Ò¸ðǰ ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è GMP ¼¼Æ÷ Ä¡·á¿ë ¼Ò¸ðǰ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ±â¾÷Àº Merck KGaA, Danaher Corporation, Sartorius AG, Thermo Fisher Scientific, General Electric, PBS Biotech, Meissner Filtration Products µîÀÔ´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¼¼°è GMP ¼¼Æ÷ Ä¡·á ¼Ò¸ðǰ ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è GMP ¼¼Æ÷ Ä¡·á¿ë ¼Ò¸ðǰ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ GMP ¼¼Æ÷ Ä¡·á¿ë ¼Ò¸ðǰ ½ÃÀå, Á¦Ç° À¯Çüº°, 2020-2032³â

Á¦5Àå ¼¼°èÀÇ GMP ¼¼Æ÷ Ä¡·á¿ë ¼Ò¸ðǰ ½ÃÀå, ¼¼Æ÷ À¯Çüº°, 2020-2032³â

Á¦6Àå ¼¼°èÀÇ GMP ¼¼Æ÷ Ä¡·á¿ë ¼Ò¸ðǰ ½ÃÀå, ¿ëµµº°, 2020-2032³â

Á¦7Àå ¼¼°èÀÇ GMP ¼¼Æ÷ Ä¡·á¿ë ¼Ò¸ðǰ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â

Á¦8Àå ¼¼°èÀÇ GMP ¼¼Æ÷ Ä¡·á¿ë ¼Ò¸ðǰ ½ÃÀå, Áö¿ªº°, 2020-2032³â

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ Ãßõ»çÇ×

Á¦11Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global GMP Cell Therapy Consumables Market is estimated to be valued at USD 18.0 Mn in 2025 and is expected to reach USD 103.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 28.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 18.0 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 28.40% 2032 Value Projection: USD 103.8 Mn
Figure. GMP Cell Therapy Consumables Market Share (%), By Region 2025
GMP Cell Therapy Consumables Market - IMG1

Global GMP cell therapy consumables market growth is driven by increasing prevalence of chronic diseases like cancer. Cell therapy involves extracting cells from patient's/ donor's body and modifying them to fight against diseases. GMP consumables play a vital role in cell therapy procedures as these ensure sterility and prevent contamination during development and manufacturing of cell therapy products. Factors such as rising funding for cell-based research, growing geriatric population susceptible to chronic illnesses and augmenting healthcare expenditure can boost demand for GMP consumables in cell therapy globally. However, high costs associated with cell therapy developments and stringent regulatory guidelines for GMP facilities can hamper the market growth.

Market Dynamics:

Global GMP cell therapy consumables market growth is driven by factors such as rising incidence of cancer and other chronic illnesses worldwide. As per WHO, cancer burden has increased to 18.1 million new cases and 9.6 million deaths in 2018. This has boosted demand for advanced treatment solutions like cell therapy, thus, boosting the need for GMP consumables. Growing investments in cell-based research by public-private organizations can drive the market growth. For instance, National Institutes of Health granted over US$ 150 million towards cell therapy research in 2022. However, high costs associated with cell therapy development and maintenance of GMP facilities can hamper the market growth. Strict regulatory standards for GMP manufacturing can hamper the wider commercialization of cell therapy products. Moreover, reimbursement issues related to cell therapies can hamper the market growth. Ongoing technological advancements in GMP consumables to simplify manufacturing processes and rising applications of cell therapies can provide growth opportunities for market players.

Key features of the study:

This report provides in-depth analysis of the global GMP cell therapy consumables market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global GMP cell therapy consumables market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Merck KGaA, Danaher Corporation, Sartorius AG, Thermo Fisher Scientific, General Electric, PBS Biotech, Meissner Filtration Products

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global GMP cell therapy consumables market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global GMP cell therapy consumables market

Detailed Segmentation-

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global GMP Cell Therapy Consumables Market, By Product Type, 2020-2032, (USD Mn)

5. Global GMP Cell Therapy Consumables Market, By Cell Type, 2020-2032, (USD Mn)

6. Global GMP Cell Therapy Consumables Market, By Application, 2020-2032, (USD Mn)

7. Global GMP Cell Therapy Consumables Market, By End User, 2020-2032, (USD Mn)

8. Global GMP Cell Therapy Consumables Market, By Region, 2020 - 2032, (USD Mn)

9. Competitive Landscape

10. Analyst Recommendations

11. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â